CLINICAL DESCRIPTION OF TREATMENT OF PEOPLE WITH CRIMEAN-CONGO HEMORRHAGIC FEVER AS A LITERATURE REVIEW

loading.default
thumbnail.default.alt

item.page.date

item.page.journal-title

item.page.journal-issn

item.page.volume-title

item.page.publisher

Scholar Express Journals

item.page.abstract

Crimean-Congo hemorrhagic fever virus (CCHF) is a tick-borne virus whose RNA consists of S, L and M segments. The virus can migrate through ticks with animals and migratory birds, and therefore it is possible to study the geographical distribution through genetic analysis [1]. Temporal and spatial analysis of the diversity of virus strains can serve as a key factor for a better understanding of the relationship between seropositivity and mortality [1]. The clinical spectrum of CCHF ranges from mild infections to severe to fatal. According to recent data, in severe cases of CCHF, hemorrhagic manifestations may develop with a mortality rate of 4 to 20%, depending on the geographical region and the quality of medical care [2].

item.page.description

item.page.citation

item.page.collections

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced